Reticulocalbin-1, encoded by the RCN1 gene, is part of the family of calcium-binding proteins located primarily in the endoplasmic reticulum (ER). This protein plays a critical role in calcium homeostasis and regulation within cells, which is vital for maintaining various cellular functions such as signal transduction, protein folding, and secretion. Reticulocalbin-1 contains multiple EF-hand domains, typical of calcium-binding proteins, allowing it to effectively bind and modulate calcium levels within the ER. Its function is crucial in processes that require precise calcium signaling, including intercellular communication and enzymatic regulation. By contributing to the maintenance of calcium storage and signaling, reticulocalbin-1 helps preserve cellular integrity and responsiveness to external and internal stimuli, impacting overall cellular health and function.
The inhibition of reticulocalbin-1 can lead to disruptions in calcium homeostasis and the general functioning of the ER, potentially resulting in ER stress and related pathologies. One mechanism of inhibition could be the direct interference with its calcium-binding ability, which may involve the alteration of its EF-hand domains through genetic mutations or post-translational modifications such as phosphorylation or oxidation. These modifications can reduce the calcium-binding affinity of reticulocalbin-1, impairing its functional capacity to regulate calcium levels effectively. Another mechanism might involve the regulation of RCN1 gene expression. Transcription factors that normally enhance the expression of RCN1 could be inhibited, or negative regulators might be activated, leading to a decrease in reticulocalbin-1 synthesis. Additionally, the overall stability and location of reticulocalbin-1 within the cell can be affected by cellular stress or changes in the ER environment, further impacting its ability to function normally. Understanding these inhibition processes is essential for comprehending the complex dynamics of ER calcium regulation and the potential cellular consequences when such regulatory mechanisms are disrupted.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin causes ER stress by inhibiting N-linked glycosylation, thereby possibly influencing reticulocalbin-1’s protein folding role. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $33.00 $102.00 | 87 | |
Salubrinal inhibits dephosphorylation of eIF2α, enhancing ER stress and thereby potentially modulating reticulocalbin-1’s activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A-23187 is a calcium ionophore that disrupts calcium homeostasis in the ER, which may indirectly influence reticulocalbin-1. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
As a calcium channel blocker, Verapamil may influence ER calcium levels and thus have an indirect effect on reticulocalbin-1. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
MLN4924 inhibits neddylation and induces ER stress, potentially impacting the environment in which reticulocalbin-1 operates. | ||||||
STF 083010 | 307543-71-1 | sc-474562 sc-474562A sc-474562B sc-474562C sc-474562D | 5 mg 10 mg 50 mg 100 mg 200 mg | $127.00 $180.00 $400.00 $700.00 $1212.00 | 3 | |
STF-083010 inhibits IRE1α, a key player in the ER stress response, thereby possibly modulating reticulocalbin-1’s role. | ||||||